Documentation Centre

 

 

  of 484 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. PLoS One. 2018;13:e0198327 January 28, 2019 Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. PLoS One. 2018;13:e0198327 Franch-Nadal J, Caballeria L, Mata-Cases M, Mauricio D, Giraldez-García C, Mancera J, Goday A, Mundet-Tudurí X, Regidor E; PREDAPS Study Group Key Publications
Perivascular fat mapping predicts cardiac death. Nat Rev Cardiol. 2018;15:656 January 22, 2019 Perivascular fat mapping predicts cardiac death. Nat Rev Cardiol. 2018;15:656 Le Bras A Key Publications
Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: A prospective study of 0.5 million people. Hepatology. 2018;68:1308-1318 January 15, 2019 Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: A prospective study of 0.5 million people. Hepatology. 2018;68:1308-1318 Pang Y, Kartsonaki C, Turnbull I, Guo Y, Clarke R, Chen Y, Bragg F, Yang L, Bian Z, Millwood IY, Hao J, Han X, Zang Y, Chen J, Li L, Holmes MV, Chen Z Key Publications
Diabetes, liver cancer, and cirrhosis: What next? Hepatology. 2018;68:1220-1222 January 14, 2019 Diabetes, liver cancer, and cirrhosis: What next? Hepatology. 2018;68:1220-1222 Yki-Järvinen H, Luukkonen PK Key Publications
Perivascular adipose tissue and coronary atherosclerosis. Heart. 2018;104:1654-1662 January 09, 2019 Perivascular adipose tissue and coronary atherosclerosis. Heart. 2018;104:1654-1662 Mancio J, Oikonomou EK, Antoniades C Key Publications
Visceral adipose tissue tracks more closely with metabolic dysfunction than intrahepatic triglyceride in lean Asians without diabetes. J Appl Physiol (1985). 2018;125:909-915 January 09, 2019 Visceral adipose tissue tracks more closely with metabolic dysfunction than intrahepatic triglyceride in lean Asians without diabetes. J Appl Physiol (1985). 2018;125:909-915 Ding C, Chan Z, Chooi YC, Choo J, Sadananthan SA, Michael N, Velan SS, Leow MKS, Magkos F Key Publications
SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases. Diabetologia. 2018;61:2134-2139 January 04, 2019 SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases. Diabetologia. 2018;61:2134-2139 Wanner C, Marx N Key Publications
Sex differences in metabolism and cardiometabolic disorders. Curr Opin Lipidol. 2018;29:404-410 December 19, 2018 Sex differences in metabolism and cardiometabolic disorders. Curr Opin Lipidol. 2018;29:404-410 Chella Krishnan K, Mehrabian M, Lusis AJ Key Publications
Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans. Am J Physiol Endocrinol Metab. 2018;315:E126-E132 November 30, 2018 Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans. Am J Physiol Endocrinol Metab. 2018;315:E126-E132 Beysen C, Ruddy M, Stoch A, Mixson L, Rosko K, Riiff T, Turner SM, Hellerstein MK, Murphy EJ. Key Publications
Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: A randomized controlled trial (E-LIFT Trial). Diabetes Care. 2018;41:1801-1808 November 29, 2018 Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: A randomized controlled trial (E-LIFT Trial). Diabetes Care. 2018;41:1801-1808 Kuchay MS, Krishan S, Mishra SK, Farooqui KJ, Singh MK, Wasir JS, Bansal B, Kaur P, Jevalikar G, Gill HK, Choudhary NS, Mithal A Key Publications

  of 484 Next page

Go to page: of